Global efforts to prevent HIV lost ground last year as funding disruptions forced countries to scale back services, even as ...

Sept 15 (Reuters) - U.S. drugmaker Gilead Sciences said on Tuesday it had reached an agreement with the Pan American Health ...

Read full article: Visit Virginia’s Blue Ridge reaches record high $972.5 million in tourism revenue in 2025 Read full article: Virginia secures more than $6.2 million in investments to strengthen ...

Dr. Reddy’s Laboratories has entered into a royalty-free non-exclusive voluntary licensing agreement with Gilead Sciences for ...

The Pan American Health Organization (PAHO) says it is opening new avenues for countries in Latin America and the Caribbean (LAC) to access lenacapavir, a long-acting HIV prevention medicine aimed at ...

HIV doesn’t discriminate, but societal barriers have left Black Americans disproportionately affected. HIV prevention options ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced the ...

Agreement aims to facilitate future manufacturing readiness and access planning across 120 high-incidence licensed countries, ...

The collaboration enables 14 countries to access lenacapavir for PrEP outside of Gilead’s current voluntary licensing ...

Gilead Sciences (NASDAQ:GILD) executives outlined plans to expand the company’s HIV prevention and treatment franchises while ...

Featured individuals were compensated for their time. Sex should feel good, pleasurable, and uninhibited. But protecting your sexual health is still an important part of the experience. HIV prevention ...